glp-1 medication semaglutide Oral Helps Patients Maintain Weight Loss | Research Jacksonville Bariatric Surgeon | Dr.

Realistic expectations: Stopping GLP-1s may worsen your glucose control initially, and you may need significantly more insulin than you needed before starting GLP-1s

Clinical observations, while valuable, lack the controls necessary for confident conclusions

The clinical studies have demonstrated the synergistic effects of GIP and GLP-1 agonism on glucose metabolism and body weight in these unimolecular dual agonists (63, 76), marking a significant achievement in the pharmaceutical development of incretins, which will be further discussed in the next section

A Comprehensive Approach for Better Outcomes By integrating GLP-1 therapies with gut health strategies and holistic lifestyle interventions, physicians can tackle metabolic dysfunction comprehensively